Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Cohort Study

Critical Care Medicine

Volumn 44, Issue 4, 2016, Pages 773-781

  Osthoff, Michael ^a   Sidler, Jan A ^a   Lakatos, Botond ^a   Frei, Reno ^a   Dangel, Marc ^a   Weisser, Maja ^a   Battegay, Manuel ^a   Widmer, Andreas F ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

acetylsalicylic acid; aspirin; bloodstream infection; propensity score analysis; Staphylococcus aureus

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; HAZARD RATIO; HOSPITAL PATIENT; HUMAN; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBSERVATIONAL METHOD; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURVIVAL; SWITZERLAND; TERTIARY CARE CENTER; TREATMENT OUTCOME; BLOOD; CROSS INFECTION; ESCHERICHIA COLI INFECTIONS; HOSPITAL MORTALITY; ISOLATION AND PURIFICATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; STAPHYLOCOCCAL INFECTIONS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BACTEREMIA; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SWITZERLAND;

EID: 84953302779     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001554     Document Type: Article

References (42)

1. Laupland KB, Incidence of bloodstream infection: A review of population-based studies. Clin Microbiol Infect 2013 19 492 500
2. López-Cortés LE, Del Toro MD, Gálvez-Acebal J, REIPI/SAB Group Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013 57 1225 1233
3. Curkovic I, Egbring M, Kullak-Ublick GA, Thrombocyte aggregation inhibitors: What are the risks? Praxis (Bern 1994) 2013 102 1243 1250
4. Eisen DP, Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis. Intensive Care Med 2012 38 1249 1257
5. Russwurm S, Vickers J, Meier-Hellmann A, Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 2002 17 263 268
6. Gawaz M, Fateh-Moghadam S, Pilz G, Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995 25 843 851
7. Gawaz M, Dickfeld T, Bogner C, Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997 23 379 385
8. Kupferwasser LI, Yeaman MR, Nast CC, Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003 112 222 233
9. Kupferwasser LI, Yeaman MR, Shapiro SM, Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999 99 2791 2797
10. Nicolau DP, Freeman CD, Nightingale CH, Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 1993 61 1593 1595
11. Nicolau DP, Marangos MN, Nightingale CH, Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1995 39 1748 1751
12. Nicolau DP, Tessier PR, Nightingale CH, Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 1999 11 159 161
13. Sedlacek M, Gemery JM, Cheung AL, Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 2007 49 401 408
14. Que YA, Haefliger JA, Piroth L, Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005 201 1627 1635
15. Xiong YQ, Willard J, Yeaman MR, Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 2006 194 1267 1275
16. Eisen DP, Reid D, McBryde ES, Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med 2012 40 1761 1767
17. Otto GP, Sossdorf M, Boettel J, Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets 2013 24 480 485
18. Winning J, Reichel J, Eisenhut Y, Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms. Platelets 2009 20 50 57
19. López-Cortés LE, Gálvez-Acebal J, Del Toro MD, Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: A prospective cohort study. PLoS One 2013 8 e82958
20. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2011 2 1 138
21. Charlson M, Szatrowski TP, Peterson J, Validation of a combined comorbidity index. J Clin Epidemiol 1994 47 1245 1251
22. Hurley JC, Comparison of mortality associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: An ecological analysis. Clin Infect Dis 2003 37 866 868
23. Fowler VG, Allen KB, Moreira ED, Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: A randomized trial. JAMA 2013 309 1368 1378
24. Thwaites G, Auckland C, Barlow G, United Kingdom Clinical Infection Research Group Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): Study protocol for a randomised controlled trial. Trials 2012 13 241
25. Marshall JC, Why have clinical trials in sepsis failed? Trends Mol Med 2014 20 195 203
26. Eisen DP, Corey GR, McBryde ES, ICE Investigators Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. J Infect 2009 58 332 338
27. Naber CK, Staphylococcus aureus bacteremia: Epidemiology, pathophysiology, and management strategies. Clin Infect Dis 2009 48 Suppl 4 S231 S237
28. Price CT, Lee IR, Gustafson JE, The effects of salicylate on bacteria. Int J Biochem Cell Biol 2000 32 1029 1043
29. Stables MJ, Newson J, Ayoub SS, Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and-resistant bacteria. Blood 2010 116 2950 2959
30. Lorente JA, Marshall JC, Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 2005 24 Suppl 1 107 119
31. Mehl A, Harthug S, Lydersen S, Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: A prospective observational study. Eur J Clin Microbiol Infect Dis 2015 34 609 617
32. Chan KL, Dumesnil JG, Cujec B, Investigators of the Multicenter Aspirin Study in Infective Endocarditis A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003 42 775 780
33. Spite M, Serhan CN, Novel lipid mediators promote resolution of acute inflammation: Impact of aspirin and statins. Circ Res 2010 107 1170 1184
34. Boyle AJ, Di Gangi S, Hamid UI, Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: A prospective analysis. Crit Care 2015 19 109
35. Chen W, Janz DR, Bastarache JA, Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: A propensity-adjusted analysis. Crit Care Med 2015 43 801 807
36. Janda S, Young A, Fitzgerald JM, The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis. J Crit Care 2010 25 656.e7 656.22
37. Goodin J, Manrique C, Dulohery M, Effect of statins on the clinical outcomes of patients with sepsis. Anaesth Intensive Care 2011 39 1051 1055
38. Deshpande A, Pasupuleti V, Rothberg MB, Statin therapy and mortality from sepsis: A meta-analysis of randomized trials. Am J Med 2015 128 410.e1 417.e1
39. Neely LA, Audeh M, Phung NA, T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 2013 5 182ra54
40. Kothari A, Morgan M, Haake DA, Emerging technologies for rapid identification of bloodstream pathogens. Clin Infect Dis 2014 59 272 278
41. Polgreen LA, Cook EA, Brooks JM, Increased statin prescribing does not lower pneumonia risk. Clin Infect Dis 2015 60 1760 1766
42. Widmer AF, Lakatos B, Frei R, Strict infection control leads to low incidence of methicillin-resistant Staphylococcus aureus bloodstream infection over 20 years. Infect Control Hosp Epidemiol 2015 36 702 709